Curtis L. Cetrulo
Fondateur chez Auxocell Laboratories, Inc.
Profil
Curtis L.
Cetrulo is a medical consultant and founder of Auxocell Laboratories, Inc. which is founded in 2008.
He is currently an independent director at OptMed, Inc. since 2022 and an associate professor-surgery at Harvard Medical School since 2009.
Dr. Cetrulo received his doctorate degree from Tufts University School of Medicine in 1999.
Postes actifs de Curtis L. Cetrulo
Sociétés | Poste | Début |
---|---|---|
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/05/2022 |
Harvard Medical School | Corporate Officer/Principal | 01/01/2009 |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | Fondateur | 01/01/2008 |
Formation de Curtis L. Cetrulo
Tufts University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | Health Technology |